Skip navigation

New J&J anti-depressant related to "Special K" party drug

   NEW BRUNSWICK, New Jersey (Reuters) - Johnson & Johnson said it plans to seek approvals for 11 new drugs by 2017, including a new type of treatment for patients with depression that have failed to benefit from standard medications. Full story

New drugs aim to increase female desire

   Studies show between one and four years into a relationship, a woman’s sexual interest begins to wane, but new drugs are being developed to adjust reduced desire. TODAY’s Savannah Guthrie reports and relationship experts Ian Kerner and Logan Levkoff discuss the pills, calling female sexuality “hugel

J&J forecasts 10 new drug applications by 2017

Johnson & Johnson says it plans to submit more than 10 new treatments to regulators for approval and 25 applications for additional uses of approved drugs by 2017. Full story

BTG says interventional medicine buys could boost sales to $1 bln

LONDON (Reuters) - British pharmaceutical company BTG announced two deals on Thursday that it said could create an interventional medicine business with potential sales of $1 billion. Full story

Merck's insomnia drug moves a step closer to U.S. approval

WASHINGTON (Reuters) - Merck & Co's experimental insomnia drug moved a step closer to U.S. approval on Wednesday after a panel of medical experts said it is effective and safe at lower doses. Full story

Senate committee advances drug compounding bill

NEW YORK (Reuters) - A U.S. Senate committee on Wednesday unanimously approved legislation that would increase federal oversight for companies that compound and sell sterile drugs across state lines. Full story

Sponsored Links

Articles

Faith healers charged with murder after 2nd death

Thrifty Merrimack developing new cancer drugs at lower cost

Regeneron moves higher on asthma drug study data

Amag slumps on Ferahame recall in Switzerland

Glaxo, US partnering to develop new antibiotics

Oncolytics cancer drug meets mid-stage trial goal, shares rise

Immune system cancer drugs tipped to be a $35 billion market

Merck signs $5 billion share buyback agreement with Goldman Sachs

Amag says anemia drug caused fatal reaction in Switzerland

Biogen submits new MS drug for FDA approval

Video

  Chopak brothers chronicle their journey to the US

Deepak and Sanjiv Chopra joing Morning Joe to discuss their new book, which chronicles the bonds of brotherhood between them.

  Is the class of 2013 really ready for what’s next?

Class of 2013 graduates Brittany Brathwaite from Syracuse University and Victoria Bashan from Marymount Manhattan College join Melissa Harris-Perry to talk about student loan debt and thinking about the long-term.

  'Wild, Wild Web', Part 2

Chris Hansen check up on a distributor of the 'pleasure pill'. 

  Medical research impacted by continuing sequester

Chris Matthews talks with Francis Collins, director of the National Institute of Health, about how sequester cuts are affecting NIH. The Grio’s Joy Reid also joins the conversations.

  May 15: 'Behind Closed Doors', Part 3

Detectives next interview Ruth Pyne's son, Jeffrey, a popular honor student and star athlete in high school, now a biology major in college.

advertisement | ad info

Related Photos

A man, wearing a surgical mask as a precautionary measure against the novel coronavirus, pays for medicine at a hospital pharmacy in Khobar city
A man, wearing a surgical mask as a precautionary measure against the novel coronavirus, pays for medicine at a hospital pharmacy in Khobar city

A man, wearing a surgical mask as a precautionary measure against the novel coronavirus, pays for medicine at a hospital pharmacy in Khobar city in Dammam May 21, 2013. REUTERS/Stringer (SAUDI ARABIA - Tags: HEALTH SOCIETY)

An employee prepares traditional Chinese herbal medicine at a store in Beijing
An employee prepares traditional Chinese herbal medicine at a store in Beijing

An employee prepares traditional Chinese herbal medicine at a store in Beijing, May 14, 2013. REUTERS/Jason Lee (CHINA - Tags: HEALTH SOCIETY)

Fecal donor Dr. Hunter Johnson
Fecal donor Dr. Hunter Johnson

Dr. Hunter Johnson, a pathology resident at the Emory University School of Medicine, is seen in a lab at the hospital in Atlanta, Georgia, USA, 05 April 2013. Johnson has recently been a stool donor to at least four patients involved in a novel program at Emory that uses donated stool to perform fec